{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:06:44Z","timestamp":1778915204133,"version":"3.51.4"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,1,10]],"date-time":"2014-01-10T00:00:00Z","timestamp":1389312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pflugers Arch - Eur J Physiol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s00424-013-1427-5","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T08:08:49Z","timestamp":1389254929000},"page":"811-818","source":"Crossref","is-referenced-by-count":21,"title":["Low-voltage-activated T-type Ca2+ channel inhibitors as new tools in the treatment of glioblastoma: the role of endostatin"],"prefix":"10.1007","volume":"466","author":[{"given":"Yuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"1427_CR1","first-page":"707","volume":"9","author":"F Belardetti","year":"2008","unstructured":"Belardetti F, Zamponi GW (2008) Linking calcium-channel isoforms to potential therapies. Curr Opin Investig Drugs 9:707\u2013715","journal-title":"Curr Opin Investig Drugs"},{"key":"1427_CR2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1124\/mol.62.2.210","volume":"62","author":"GE Bertolesi","year":"2002","unstructured":"Bertolesi GE, Shi C, Elbaum L, Jollimore C, Rozenberg G, Barnes S, Kelly ME (2002) The Ca(2+) channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms. Mol Pharmacol 62:210\u2013219","journal-title":"Mol Pharmacol"},{"key":"1427_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.emboj.7600515","volume":"24","author":"E Bourinet","year":"2005","unstructured":"Bourinet E, Alloui A, Monteil A, Barrere C, Couette B, Poirot O, Pages A, McRory J, Snutch TP, Eschalier A, Nargeot J (2005) Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J 24:315\u2013324","journal-title":"EMBO J"},{"key":"1427_CR4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/chan.4.6.14106","volume":"4","author":"SM Cain","year":"2010","unstructured":"Cain SM, Snutch TP (2010) Contributions of T-type calcium channel isoforms to neuronal firing. Channels (Austin) 4:475\u2013482","journal-title":"Channels (Austin)"},{"key":"1427_CR5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ceca.2006.04.019","volume":"40","author":"E Carbone","year":"2006","unstructured":"Carbone E, Giancippoli A, Marcantoni A, Guido D, Carabelli V (2006) A new role for T-type channels in fast \u201clow-threshold\u201d exocytosis. Cell Calcium 40:147\u2013154","journal-title":"Cell Calcium"},{"key":"1427_CR6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.cellbio.16.1.521","volume":"16","author":"WA Catterall","year":"2000","unstructured":"Catterall WA (2000) Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol 16:521\u2013555","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1427_CR7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/pr.57.4.5","volume":"57","author":"WA Catterall","year":"2005","unstructured":"Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J (2005) International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57:411\u2013425","journal-title":"Pharmacol Rev"},{"key":"1427_CR8","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0006-3495(01)76100-0","volume":"80","author":"J Chemin","year":"2001","unstructured":"Chemin J, Monteil A, Bourinet E, Nargeot J, Lory P (2001) Alternatively spliced alpha(1G) (Ca(V)3.1) intracellular loops promote specific T-type Ca(2+) channel gating properties. Biophys J 80:1238\u20131250","journal-title":"Biophys J"},{"key":"1427_CR9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0014-5793(00)01832-9","volume":"478","author":"J Chemin","year":"2000","unstructured":"Chemin J, Monteil A, Briquaire C, Richard S, Perez-Reyes E, Nargeot J, Lory P (2000) Overexpression of T-type calcium channels in HEK-293 cells increases intracellular calcium without affecting cellular proliferation. FEBS Lett 478:166\u2013172","journal-title":"FEBS Lett"},{"key":"1427_CR10","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1046\/j.0953-816x.2001.01796.x","volume":"14","author":"J Chemin","year":"2001","unstructured":"Chemin J, Monteil A, Dubel S, Nargeot J, Lory P (2001) The alpha1I T-type calcium channel exhibits faster gating properties when overexpressed in neuroblastoma\/glioma NG 108-15 cells. Eur J Neurosci 14:1678\u20131686","journal-title":"Eur J Neurosci"},{"key":"1427_CR11","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1074\/jbc.M610033200","volume":"282","author":"J Chemin","year":"2007","unstructured":"Chemin J, Nargeot J, Lory P (2007) Chemical determinants involved in anandamide-induced inhibition of T-type calcium channels. J Biol Chem 282:2314\u20132323","journal-title":"J Biol Chem"},{"key":"1427_CR12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ceca.2006.04.015","volume":"40","author":"J Chemin","year":"2006","unstructured":"Chemin J, Traboulsie A, Lory P (2006) Molecular pathways underlying the modulation of T-type calcium channels by neurotransmitters and hormones. Cell Calcium 40:121\u2013134","journal-title":"Cell Calcium"},{"key":"1427_CR13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/368875a0","volume":"368","author":"B Ciapa","year":"1994","unstructured":"Ciapa B, Pesando D, Wilding M, Whitaker M (1994) Cell-cycle calcium transients driven by cyclic changes in inositol trisphosphate levels. Nature 368:875\u2013878","journal-title":"Nature"},{"key":"1427_CR14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ceca.2006.04.026","volume":"40","author":"LL Cribbs","year":"2006","unstructured":"Cribbs LL (2006) T-type Ca2+ channels in vascular smooth muscle: multiple functions. Cell Calcium 40:221\u2013230","journal-title":"Cell Calcium"},{"key":"1427_CR15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4161\/chan.4.6.12870","volume":"4","author":"L Cribbs","year":"2010","unstructured":"Cribbs L (2010) T-type calcium channel expression and function in the diseased heart. Channels (Austin) 4:447\u2013452","journal-title":"Channels (Austin)"},{"key":"1427_CR16","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1523\/JNEUROSCI.10-10-03361.1990","volume":"10","author":"SS Garber","year":"1990","unstructured":"Garber SS, Hoshi T, Aldrich RW (1990) Interaction of forskolin with voltage-gated K\u2009+\u2009channels in PC12 cells. J Neurosci 10:3361\u20133368","journal-title":"J Neurosci"},{"key":"1427_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1517\/13543776.2011.536532","volume":"21","author":"F Giordanetto","year":"2011","unstructured":"Giordanetto F, Knerr L, Wallberg A (2011) T-type calcium channels inhibitors: a patent review. Expert Opin Ther Patent 21:85\u2013101","journal-title":"Expert Opin Ther Patent"},{"key":"1427_CR18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ceca.2006.04.014","volume":"40","author":"LS Gray","year":"2006","unstructured":"Gray LS, Macdonald TL (2006) The pharmacology and regulation of T type calcium channels: new opportunities for unique therapeutics for cancer. Cell Calcium 40:115\u2013120","journal-title":"Cell Calcium"},{"key":"1427_CR19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ceca.2004.05.001","volume":"36","author":"LS Gray","year":"2004","unstructured":"Gray LS, Perez-Reyes E, Gomora JC, Haverstick DM, Shattock M, McLatchie L, Harper J, Brooks G, Heady T, Macdonald TL (2004) The role of voltage gated T-type Ca2+ channel isoforms in mediating \u201ccapacitative\u201d Ca2+ entry in cancer cells. Cell Calcium 36:489\u2013497","journal-title":"Cell Calcium"},{"key":"1427_CR20","first-page":"1002","volume":"60","author":"DM Haverstick","year":"2000","unstructured":"Haverstick DM, Heady TN, Macdonald TL, Gray LS (2000) Inhibition of human prostate cancer proliferation in vitro and in a mouse model by a compound synthesized to block Ca2+ entry. Cancer Res 60:1002\u20131008","journal-title":"Cancer Res"},{"key":"1427_CR21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/jpet.103.060814","volume":"309","author":"L Huang","year":"2004","unstructured":"Huang L, Keyser BM, Tagmose TM, Hansen JB, Taylor JT, Zhuang H, Zhang M, Ragsdale DS, Li M (2004) NNC 55-0396 [(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2, 3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels. J Pharmacol Exp Ther 309:193\u2013199","journal-title":"J Pharmacol Exp Ther"},{"key":"1427_CR22","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/0008-5472.CAN-03-3501","volume":"64","author":"JB Huang","year":"2004","unstructured":"Huang JB, Kindzelskii AL, Clark AJ, Petty HR (2004) Identification of channels promoting calcium spikes and waves in HT1080 tumor cells: their apparent roles in cell motility and invasion. Cancer Res 64:2482\u20132489","journal-title":"Cancer Res"},{"key":"1427_CR23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tips.2008.10.004","volume":"30","author":"MC Iftinca","year":"2009","unstructured":"Iftinca MC, Zamponi GW (2009) Regulation of neuronal T-type calcium channels. Trends Pharmacol Sci 30:32\u201340","journal-title":"Trends Pharmacol Sci"},{"key":"1427_CR24","doi-asserted-by":"crossref","first-page":"27872","DOI":"10.1074\/jbc.M202771200","volume":"277","author":"YM Kim","year":"2002","unstructured":"Kim YM, Hwang S, Pyun BJ, Kim TY, Lee ST, Gho YS, Kwon YG (2002) Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR\/Flk-1. J Biol Chem 277:27872\u201327879","journal-title":"J Biol Chem"},{"key":"1427_CR25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0896-6273(01)00343-9","volume":"31","author":"D Kim","year":"2001","unstructured":"Kim D, Song I, Keum S, Lee T, Jeong MJ, Kim SS, McEnery MW, Shin HS (2001) Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels. Neuron 31:35\u201345","journal-title":"Neuron"},{"key":"1427_CR26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00232-005-0781-4","volume":"205","author":"K Kunzelmann","year":"2005","unstructured":"Kunzelmann K (2005) Ion channels and cancer. J Membr Biol 205:159\u2013173","journal-title":"J Membr Biol"},{"key":"1427_CR27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/1568007043482543","volume":"3","author":"L Lacinova","year":"2004","unstructured":"Lacinova L (2004) Pharmacology of recombinant low-voltage activated calcium channels. Curr Drug Targets CNS Neurol Disord 3:105\u2013111","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"1427_CR28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/glia.20063","volume":"48","author":"I Latour","year":"2004","unstructured":"Latour I, Louw DF, Beedle AM, Hamid J, Sutherland GR, Zamponi GW (2004) Expression of T-type calcium channel splice variants in human glioma. Glia 48:112\u2013119","journal-title":"Glia"},{"key":"1427_CR29","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1523\/JNEUROSCI.19-06-01912.1999","volume":"19","author":"JH Lee","year":"1999","unstructured":"Lee JH, Daud AN, Cribbs LL, Lacerda AE, Pereverzev A, Klockner U, Schneider T, Perez-Reyes E (1999) Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family. J Neurosci 19:1912\u20131921","journal-title":"J Neurosci"},{"key":"1427_CR30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0024-3205(85)90120-1","volume":"36","author":"GL Lee","year":"1985","unstructured":"Lee GL, Hait WN (1985) Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulin. Life Sci 36:347\u2013354","journal-title":"Life Sci"},{"key":"1427_CR31","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1016\/j.bmcl.2004.04.090","volume":"14","author":"YS Lee","year":"2004","unstructured":"Lee YS, Lee BH, Park SJ, Kang SB, Rhim H, Park JY, Lee JH, Jeong SW, Lee JY (2004) 3,4-Dihydroquinazoline derivatives as novel selective T-type Ca2+ channel blockers. Bioorg Med Chem Lett 14:3379\u20133384","journal-title":"Bioorg Med Chem Lett"},{"key":"1427_CR32","first-page":"156","volume":"3","author":"M Li","year":"2011","unstructured":"Li M, Xiong ZG (2011) Ion channels as targets for cancer therapy. Int J Physiol Pathophysiol Pharmacol 3:156\u2013166","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"1427_CR33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/07357907.2011.568565","volume":"29","author":"W Li","year":"2011","unstructured":"Li W, Zhang SL, Wang N, Zhang BB, Li M (2011) Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation. Cancer Invest 29:339\u2013346","journal-title":"Cancer Invest"},{"key":"1427_CR34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ceca.2006.04.017","volume":"40","author":"P Lory","year":"2006","unstructured":"Lory P, Bidaud I, Chemin J (2006) T-type calcium channels in differentiation and proliferation. Cell Calcium 40:135\u2013146","journal-title":"Cell Calcium"},{"key":"1427_CR35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ceca.2007.03.006","volume":"43","author":"F Lu","year":"2008","unstructured":"Lu F, Chen H, Zhou C, Liu S, Guo M, Chen P, Zhuang H, Xie D, Wu S (2008) T-type Ca2+ channel expression in human esophageal carcinomas: a functional role in proliferation. Cell Calcium 43:49\u201358","journal-title":"Cell Calcium"},{"key":"1427_CR36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ceca.2005.09.005","volume":"38","author":"F Lu","year":"2005","unstructured":"Lu F, Chen H, Zhou C, Wu S (2005) Is there a role for T-type Ca2+ channel in glioma cell proliferation? Cell Calcium 38:593\u2013595, author reply 597","journal-title":"Cell Calcium"},{"key":"1427_CR37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ceca.2011.05.004","volume":"49","author":"K Machaca","year":"2011","unstructured":"Machaca K (2011) Ca(2+) signaling, genes and the cell cycle. Cell Calcium 49:323\u2013330","journal-title":"Cell Calcium"},{"key":"1427_CR38","doi-asserted-by":"crossref","first-page":"10824","DOI":"10.1074\/jbc.M108754200","volume":"277","author":"P Mariot","year":"2002","unstructured":"Mariot P, Vanoverberghe K, Lalevee N, Rossier MF, Prevarskaya N (2002) Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells. J Biol Chem 277:10824\u201310833","journal-title":"J Biol Chem"},{"key":"1427_CR39","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1126\/science.295.5563.2198","volume":"295","author":"E Marshall","year":"2002","unstructured":"Marshall E (2002) Cancer therapy. Setbacks for endostatin. Science 295:2198\u20132199","journal-title":"Science"},{"key":"1427_CR40","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1016\/j.bmcl.2004.05.011","volume":"14","author":"WF McCalmont","year":"2004","unstructured":"McCalmont WF, Heady TN, Patterson JR, Lindenmuth MA, Haverstick DM, Gray LS, Macdonald TL (2004) Design, synthesis, and biological evaluation of novel T-Type calcium channel antagonists. Bioorg Med Chem Lett 14:3691\u20133695","journal-title":"Bioorg Med Chem Lett"},{"key":"1427_CR41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2174\/187152706779025535","volume":"5","author":"JG McGivern","year":"2006","unstructured":"McGivern JG (2006) Pharmacology and drug discovery for T-type calcium channels. CNS Neurol Disord Drug Targets 5:587\u2013603","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1427_CR42","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1074\/jbc.M008215200","volume":"276","author":"JE McRory","year":"2001","unstructured":"McRory JE, Santi CM, Hamming KS, Mezeyova J, Sutton KG, Baillie DL, Stea A, Snutch TP (2001) Molecular and functional characterization of a family of rat brain T-type calcium channels. J Biol Chem 276:3999\u20134011","journal-title":"J Biol Chem"},{"key":"1427_CR43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4161\/chan.4.6.12867","volume":"4","author":"DL Minor Jr","year":"2010","unstructured":"Minor DL Jr, Findeisen F (2010) Progress in the structural understanding of voltage-gated calcium channel (CaV) function and modulation. Channels (Austin) 4:459\u2013474","journal-title":"Channels (Austin)"},{"key":"1427_CR44","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.1074\/jbc.275.9.6090","volume":"275","author":"A Monteil","year":"2000","unstructured":"Monteil A, Chemin J, Bourinet E, Mennessier G, Lory P, Nargeot J (2000) Molecular and functional properties of the human alpha(1G) subunit that forms T-type calcium channels. J Biol Chem 275:6090\u20136100","journal-title":"J Biol Chem"},{"key":"1427_CR45","doi-asserted-by":"crossref","first-page":"16530","DOI":"10.1074\/jbc.C000090200","volume":"275","author":"A Monteil","year":"2000","unstructured":"Monteil A, Chemin J, Leuranguer V, Altier C, Mennessier G, Bourinet E, Lory P, Nargeot J (2000) Specific properties of T-type calcium channels generated by the human alpha 1I subunit. J Biol Chem 275:16530\u201316535","journal-title":"J Biol Chem"},{"key":"1427_CR46","doi-asserted-by":"crossref","first-page":"31666","DOI":"10.1074\/jbc.R112.343061","volume":"287","author":"GR Monteith","year":"2012","unstructured":"Monteith GR, Davis FM, Roberts-Thomson SJ (2012) Calcium channels and pumps in cancer: changes and consequences. J Biol Chem 287:31666\u201331673","journal-title":"J Biol Chem"},{"key":"1427_CR47","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0014-5793(02)03341-0","volume":"528","author":"J Murbartian","year":"2002","unstructured":"Murbartian J, Arias JM, Lee JH, Gomora JC, Perez-Reyes E (2002) Alternative splicing of the rat Ca(v)3.3 T-type calcium channel gene produces variants with distinct functional properties(1). FEBS Lett 528:272\u2013278","journal-title":"FEBS Lett"},{"key":"1427_CR48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bjp.0701140","volume":"121","author":"B Nilius","year":"1997","unstructured":"Nilius B, Prenen J, Kamouchi M, Viana F, Voets T, Droogmans G (1997) Inhibition by mibefradil, a novel calcium channel antagonist, of Ca(2+)- and volume-activated Cl- channels in macrovascular endothelial cells. Br J Pharmacol 121:547\u2013555","journal-title":"Br J Pharmacol"},{"key":"1427_CR49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ceca.2004.07.002","volume":"37","author":"A Panner","year":"2005","unstructured":"Panner A, Cribbs LL, Zainelli GM, Origitano TC, Singh S, Wurster RD (2005) Variation of T-type calcium channel protein expression affects cell division of cultured tumor cells. Cell Calcium 37:105\u2013119","journal-title":"Cell Calcium"},{"key":"1427_CR50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ceca.2006.04.029","volume":"40","author":"A Panner","year":"2006","unstructured":"Panner A, Wurster RD (2006) T-type calcium channels and tumor proliferation. Cell Calcium 40:253\u2013259","journal-title":"Cell Calcium"},{"key":"1427_CR51","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1016\/j.bmc.2006.01.005","volume":"14","author":"SJ Park","year":"2006","unstructured":"Park SJ, Lee MJ, Rhim H, Kim Y, Lee JH, Chung BY, Lee JY (2006) Synthesis and SAR studies of a novel series of T-type calcium channel blockers. Bioorg Med Chem 14:3502\u20133511","journal-title":"Bioorg Med Chem"},{"key":"1427_CR52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1152\/physrev.00018.2002","volume":"83","author":"E Perez-Reyes","year":"2003","unstructured":"Perez-Reyes E (2003) Molecular physiology of low-voltage-activated t-type calcium channels. Physiol Rev 83:117\u2013161","journal-title":"Physiol Rev"},{"key":"1427_CR53","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/36110","volume":"391","author":"E Perez-Reyes","year":"1998","unstructured":"Perez-Reyes E, Cribbs LL, Daud A, Lacerda AE, Barclay J, Williamson MP, Fox M, Rees M, Lee JH (1998) Molecular characterization of a neuronal low-voltage-activated T-type calcium channel. Nature 391:896\u2013900","journal-title":"Nature"},{"key":"1427_CR54","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2174\/187152706779025508","volume":"5","author":"E Perez-Reyes","year":"2006","unstructured":"Perez-Reyes E, Lory P (2006) Molecular biology of T-type calcium channels. CNS Neurol Disord Drug Targets 5:605\u2013609","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1427_CR55","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/ijc.10115","volume":"97","author":"I Peroulis","year":"2002","unstructured":"Peroulis I, Jonas N, Saleh M (2002) Antiangiogenic activity of endostatin inhibits C6 glioma growth. Int J Cancer 97:839\u2013845","journal-title":"Int J Cancer"},{"key":"1427_CR56","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0167-4838(92)90042-C","volume":"1160","author":"S Richard","year":"1992","unstructured":"Richard S, Neveu D, Carnac G, Bodin P, Travo P, Nargeot J (1992) Differential expression of voltage-gated Ca(2+)-currents in cultivated aortic myocytes. Biochim Biophys Acta 1160:95\u2013104","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 1","key":"1427_CR57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1469-7793.1998.093bz.x","volume":"510","author":"B Rouzaire-Dubois","year":"1998","unstructured":"Rouzaire-Dubois B, Dubois JM (1998) K\u2009+\u2009channel block-induced mammalian neuroblastoma cell swelling: a possible mechanism to influence proliferation. J Physiol 510(Pt 1):93\u2013102","journal-title":"J Physiol"},{"key":"1427_CR58","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1476-5381.2012.01908.x","volume":"166","author":"G Santoni","year":"2012","unstructured":"Santoni G, Santoni M, Nabissi M (2012) Functional role of T-type calcium channels in tumour growth and progression: prospective in cancer therapy. Br J Pharmacol 166:1244\u20131246","journal-title":"Br J Pharmacol"},{"key":"1427_CR59","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1158\/1078-0432.CCR-03-0052","volume":"10","author":"NO Schmidt","year":"2004","unstructured":"Schmidt NO, Ziu M, Carrabba G, Giussani C, Bello L, Sun Y, Schmidt K, Albert M, Black PM, Carroll RS (2004) Antiangiogenic therapy by local intracerebral microinfusion improves treatment efficiency and survival in an orthotopic human glioblastoma model. Clin Cancer Res 10:1255\u20131262","journal-title":"Clin Cancer Res"},{"key":"1427_CR60","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/01.ATV.15.8.1161","volume":"15","author":"R Schmitt","year":"1995","unstructured":"Schmitt R, Clozel JP, Iberg N, Buhler FR (1995) Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel. Arterioscler Thromb Vasc Biol 15:1161\u20131165","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1427_CR61","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1476-5381.2010.00786.x","volume":"160","author":"A Singh","year":"2010","unstructured":"Singh A, Hildebrand ME, Garcia E, Snutch TP (2010) The transient receptor potential channel antagonist SKF96365 is a potent blocker of low-voltage-activated T-type calcium channels. Br J Pharmacol 160:1464\u20131475","journal-title":"Br J Pharmacol"},{"key":"1427_CR62","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2004-03-1164","volume":"105","author":"DK Skovseth","year":"2005","unstructured":"Skovseth DK, Veuger MJ, Sorensen DR, De Angelis PM, Haraldsen G (2005) Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. Blood 105:1044\u20131051","journal-title":"Blood"},{"key":"1427_CR63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ceca.2006.04.013","volume":"40","author":"K Talavera","year":"2006","unstructured":"Talavera K, Nilius B (2006) Biophysics and structure-function relationship of T-type Ca2+ channels. Cell Calcium 40:97\u2013114","journal-title":"Cell Calcium"},{"key":"1427_CR64","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1085\/jgp.200409050","volume":"124","author":"K Talavera","year":"2004","unstructured":"Talavera K, Staes M, Janssens A, Droogmans G, Nilius B (2004) Mechanism of arachidonic acid modulation of the T-type Ca2+ channel alpha1G. J Gen Physiol 124:225\u2013238","journal-title":"J Gen Physiol"},{"key":"1427_CR65","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.3748\/wjg.14.4984","volume":"14","author":"JT Taylor","year":"2008","unstructured":"Taylor JT, Zeng XB, Pottle JE, Lee K, Wang AR, Yi SG, Scruggs JA, Sikka SS, Li M (2008) Calcium signaling and T-type calcium channels in cancer cell cycling. World J Gastroenterol 14:4984\u20134991","journal-title":"World J Gastroenterol"},{"key":"1427_CR66","first-page":"4535","volume":"59","author":"M Toyota","year":"1999","unstructured":"Toyota M, Ho C, Ohe-Toyota M, Baylin SB, Issa JP (1999) Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5\u2032 CpG island in human tumors. Cancer Res 59:4535\u20134541","journal-title":"Cancer Res"},{"key":"1427_CR67","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1471-4159.2008.05759.x","volume":"108","author":"T Trimarchi","year":"2009","unstructured":"Trimarchi T, Pachuau J, Shepherd A, Dey D, Martin-Caraballo M (2009) CNTF-evoked activation of JAK and ERK mediates the functional expression of T-type Ca2+ channels in chicken nodose neurons. J Neurochem 108:246\u2013259","journal-title":"J Neurochem"},{"key":"1427_CR68","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4161\/chan.5.5.16473","volume":"5","author":"RW Turner","year":"2011","unstructured":"Turner RW, Anderson D, Zamponi GW (2011) Signaling complexes of voltage-gated calcium channels. Channels (Austin) 5:440\u2013448","journal-title":"Channels (Austin)"},{"key":"1427_CR69","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ceca.2006.04.025","volume":"40","author":"G Vassort","year":"2006","unstructured":"Vassort G, Talavera K, Alvarez JL (2006) Role of T-type Ca2+ channels in the heart. Cell Calcium 40:205\u2013220","journal-title":"Cell Calcium"},{"key":"1427_CR70","first-page":"659","volume":"29","author":"YQ Wang","year":"2002","unstructured":"Wang YQ, Brooks G, Zhu CB, Yuan WZ, Li YQ, Wu XS (2002) Functional analysis of the human T-type calcium channel alpha 1H subunit gene in cellular proliferation. Yi Chuan Xue Bao 29:659\u2013665","journal-title":"Yi Chuan Xue Bao"},{"key":"1427_CR71","doi-asserted-by":"crossref","first-page":"C1239","DOI":"10.1152\/ajpcell.1993.265.5.C1239","volume":"265","author":"Z Wang","year":"1993","unstructured":"Wang Z, Estacion M, Mordan LJ (1993) Ca2+ influx via T-type channels modulates PDGF-induced replication of mouse fibroblasts. Am J Physiol 265:C1239\u2013C1246","journal-title":"Am J Physiol"},{"key":"1427_CR72","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tips.2004.01.009","volume":"25","author":"G Wang","year":"2004","unstructured":"Wang G, Lemos JR, Iadecola C (2004) Herbal alkaloid tetrandrine: from an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol Sci 25:120\u2013123","journal-title":"Trends Pharmacol Sci"},{"key":"1427_CR73","first-page":"5580","volume":"62","author":"SA Wickstrom","year":"2002","unstructured":"Wickstrom SA, Alitalo K, Keski-Oja J (2002) Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res 62:5580\u20135589","journal-title":"Cancer Res"},{"key":"1427_CR74","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1469-7793.2001.0661e.x","volume":"532","author":"R Wondergem","year":"2001","unstructured":"Wondergem R, Gong W, Monen SH, Dooley SN, Gonce JL, Conner TD, Houser M, Ecay TW, Ferslew KE (2001) Blocking swelling-activated chloride current inhibits mouse liver cell proliferation. J Physiol 532:661\u2013672","journal-title":"J Physiol"},{"key":"1427_CR75","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1073\/pnas.87.12.4655","volume":"87","author":"XP Xu","year":"1990","unstructured":"Xu XP, Best PM (1990) Increase in T-type calcium current in atrial myocytes from adult rats with growth hormone-secreting tumors. Proc Natl Acad Sci U S A 87:4655\u20134659","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1427_CR76","first-page":"465","volume":"38","author":"L Yang","year":"2011","unstructured":"Yang L, Lin Z, Lin J, Weng S, Huang Q, Zhang P, Fu J (2011) Antitumor effect of endostatin overexpressed in C6 glioma cells is associated with the down-regulation of VEGF. Int J Oncol 38:465\u2013471","journal-title":"Int J Oncol"},{"key":"1427_CR77","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood-2003-07-2482","volume":"103","author":"M Yoshida","year":"2004","unstructured":"Yoshida M, Nosaka K, Yasunaga J, Nishikata I, Morishita K, Matsuoka M (2004) Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells. Blood 103:2753\u20132760","journal-title":"Blood"},{"key":"1427_CR78","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.bbamem.2012.08.032","volume":"1828","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Jiang X, Snutch TP, Tao J (2013) Modulation of low-voltage-activated T-type Ca(2)(+) channels. Biochim Biophys Acta 1828:1550\u20131559","journal-title":"Biochim Biophys Acta"},{"key":"1427_CR79","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1476-5381.2012.01852.x","volume":"166","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Zhang J, Jiang D, Zhang D, Qian Z, Liu C, Tao J (2012) Inhibition of T-type Ca(2)(+) channels by endostatin attenuates human glioblastoma cell proliferation and migration. Br J Pharmacol 166:1247\u20131260","journal-title":"Br J Pharmacol"},{"key":"1427_CR80","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/hmg\/ddl068","volume":"15","author":"X Zhong","year":"2006","unstructured":"Zhong X, Liu JR, Kyle JW, Hanck DA, Agnew WS (2006) A profile of alternative RNA splicing and transcript variation of CACNA1H, a human T-channel gene candidate for idiopathic generalized epilepsies. Hum Mol Genet 15:1497\u20131512","journal-title":"Hum Mol Genet"}],"container-title":["Pfl\u00fcgers Archiv - European Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-013-1427-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00424-013-1427-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00424-013-1427-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T02:29:05Z","timestamp":1565058545000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00424-013-1427-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,10]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1427"],"URL":"https:\/\/doi.org\/10.1007\/s00424-013-1427-5","relation":{},"ISSN":["0031-6768","1432-2013"],"issn-type":[{"value":"0031-6768","type":"print"},{"value":"1432-2013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,10]]}}}